79.80
Sol Gel Technologies Ltd stock is traded at $79.80, with a volume of 103.66K.
It is up +4.31% in the last 24 hours and down -4.97% over the past month.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
See More
Previous Close:
$76.50
Open:
$81.9
24h Volume:
103.66K
Relative Volume:
2.67
Market Cap:
$258.97M
Revenue:
$19.39M
Net Income/Loss:
$-6.13M
P/E Ratio:
-36.28
EPS:
-2.1994
Net Cash Flow:
$-33.87M
1W Performance:
+7.11%
1M Performance:
-4.97%
6M Performance:
+91.09%
1Y Performance:
+1,496%
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
Name
Sol Gel Technologies Ltd
Sector
Industry
Phone
-
Address
-
Compare SLGL vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SLGL
Sol Gel Technologies Ltd
|
79.80 | 248.26M | 19.39M | -6.13M | -33.87M | -2.1994 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Dec-31-19 | Reiterated | H.C. Wainwright | Buy |
| Dec-31-19 | Reiterated | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd Stock (SLGL) Latest News
Pharma News: Why is Sol Gel Technologies Ltd stock going up2026 Snapshot & Accurate Buy Signal Notifications - baoquankhu1.vn
Aug Setups: Is Sol Gel Technologies Ltd trading at a discount2026 Growth vs Value & Consistent Profit Trade Alerts - baoquankhu1.vn
Inflation Data: Is Sol Gel Technologies Ltd being accumulated by smart money2026 Earnings Surprises & Consistent Return Investment Signals - baoquankhu1.vn
SLGL PE Ratio & Valuation, Is SLGL Overvalued - Intellectia AI
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Cash per share of Sol-Gel Technologies Ltd. – SWB:4SG - TradingView
Sol-Gel Technologies Completes $33.1 Million Underwritten Share Offering - Global Legal Chronicle
Great Point Partners, Dr. Jay & Nordahl disclose 8.45% stake in Sol-Gel (SLGL) - Stock Titan
SLGL.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Opaleye Management Inc. Increases Stake in Sol-Gel Technologies Ltd - GuruFocus
Stock List: Research Stocks from Around the World - GuruFocus
Growth Review: Is Sol Gel Technologies Ltd impacted by rising rates2026 Short Interest & Safe Entry Point Alerts - baoquankhu1.vn
Sol-Gel Technologies Prices $33.1 Million Oversubscribed Equity Offering to Advance SGT-610 - tipranks.com
Sol-Gel (NASDAQ: SLGL) prices $33.1M oversubscribed share offering - Stock Titan
Sol‑Gel (NASDAQ: SLGL) raises ~$30.8M via 459,112‑share offering to fund SGT‑610 - Stock Titan
Opaleye Management (SLGL) linked entities buy 39,665 Sol-Gel shares - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Sol-Gel Technologies (SLGL) Prices Oversubscribed Offering, Shar - GuruFocus
SLGL Announces Offering with TD Cowen and LifeSci Capital as Man - GuruFocus
[EFFECT] Sol-Gel Technologies Ltd. SEC Filing - Stock Titan
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering - weeklyvoice.com
Sol-Gel brings in $33.1M to fund SGT-610 development - Stock Titan
Sol-Gel Technologies Ltd. announces pricing of oversubscribed underwritten offering - MarketScreener
Sol-Gel Technologies Ltd. Announces Pricing of $33.1 Million Underwritten Offering of Ordinary Shares - Quiver Quantitative
Sol-Gel Technologies Ltd. Announces Pricing Of Oversubscribed Underwritten Offering - TradingView
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering - GlobeNewswire Inc.
Opaleye (SLGL) affiliate discloses 460,335 shares, 16.52% stake - Stock Titan
Sol-Gel Technologies Ltd. (SLGL) reports Q4 loss, misses revenue estimates - MSN
If You Invested $1,000 in Sol Gel Tech (SLGL) - Stock Titan
Market Fear: Why is Sol Gel Technologies Ltd stock going upWeekly Risk Report & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Sol-Gel Technologies (NASDAQ:SLGL) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Form 144 Sol-Gel Technologies Ltd. For: 12 March By Investing.com - Investing.com Australia
Sol Gel Technologies Ltd expected to post a loss of $1.84 a shareEarnings Preview - TradingView
Retail Trends: Can Sol Gel Technologies Ltd maintain its current growth rate2026 Technicals & Weekly Market Pulse Alerts - baoquankhu1.vn
Sol Gel Technologies (SLGL) Quarterly Profit Swing Challenges Bullish Turnaround Narratives - simplywall.st
Sol‑Gel (NASDAQ: SLGL) registers resale of 656,000 ordinary shares via Form F-3 - Stock Titan
Sol-Gel Technologies Ltd. (SLGL) Announces Fourth Quarter Loss, Falls Short of Revenue Projections - Bitget
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance Singapore
Sol-Gel Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025 - The Manila Times
Sol-Gel Technologies, Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025 - Quiver Quantitative
Sol-Gel Technologies (NASDAQ: SLGL) flags losses and going concern risk in 20-F - Stock Titan
SLGL: 2025 revenue grew to $19.4M, net loss narrowed, and SGT-610 Phase 3 trial reached full enrollment - TradingView
Sol-Gel posts audited 2025 financial statements in SEC filing - Stock Titan
Sol-Gel Technologies (SLGL) COO discloses stock option positions in Form 3 - Stock Titan
Sol-Gel Technologies (SLGL) CFO details share and option holdings - Stock Titan
Director Gottfried Ran details Sol-Gel Technologies (SLGL) share and option holdings - Stock Titan
Sol-Gel Technologies (SLGL) director lists 7,500 stock options at $12 - Stock Titan
Sol-Gel Technologies (SLGL) director reports 7,500-share stock option holding - Stock Titan
Sol-Gel (SLGL) director discloses fully vested 2,031 share option - Stock Titan
Sol-Gel Technologies (SLGL) director files initial insider Form 3 - Stock Titan
Sol Gel Technologies Ltd Stock (SLGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):